ProQR Therapeutics NV (PRQR) Options

Sold last week after management seems dis-organized and European companies are risky and these guys are so far early in their clinical development.

$PRQR

CEO says to expect updates of what LLY has been up to in RNA editing in 2025.

LLY participate in offering on top of 3.5bn deal... at 3.50 strike
i believe 5$ next

https://www.globenewswire.com/news-release/2024/10/23/2967435/33039/en/ProQR-Prices-75-Million-Underwritten-Public-Offering-and-Concurrent-Private-Placement.html

Doubling my position here today!

Love this technology and team

$PRQR

PRQR is WVE 2.0

Glad I loaded the day before the break out!

100k shares long Love the Lily connection and brain power from ALNY at PRQR very early pipeline buy out sooner than later.

Lily owns over 16% of PRQR

$PRQR

PRQR.........................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783

Now over 4 and still no offering after the stock doubled this week on the WVE RNA success. Believe 6$ coming.

Still has this deal with LLY:
https://finance.yahoo.com/news/eli-lilly-inks-another-rna-105803336.html

doubling down in 2022:
https://finance.yahoo.com/news/proqr-therapeutics-shares-soar-eli-135337366.html

PRQR............................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783

Looks interesting need to do more DD

may take a starter here soon.

$PRQR

PRQR under $3

the companies IR signals they are far from letting the LLY deal sour, 4bn in milestones, next payments are due soon.

LLY left none of their darligns behind so far,

PRQR under $2

PRQR under $2

PRQR under $2

added 2.01 hoping for love from LLY, 4bln in milestones.

PRQR.....................................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783

PRQR............................https://stockcharts.com/h-sc/ui?s=PRQR&p=W&b=5&g=0&id=p86431144783

PRQR under $2

PRQR under $2

$PRQR - 👆Up 7.3% Pre-Market/ Current Price $1.65
Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets

Nice rebound!

$0.4~

Ya....

Eli Lilly sends ProQR 35% higher after expanding RNA editing deal

https://seekingalpha.com/news/3919739-prqr-stock-surges-as-eli-lilly-expands-rna-editing-deal

$PRQR Strong break up the chart..on watch next week

https://stockcharts.com/c-sc/sc?s=PRQR&p=D&b=5&g=0&i=0&r=1668863394516

Time for a bounce … I hope :)

$4 is the lowest consensus I can find here:
https://etfdailynews.com/news/proqr-therapeutics-nasdaqprqr-pt-lowered-to-8-00/

What say you?

Also, when do we know it stopped dropping?

....looking for a 80 cent deadcat bounce?????

PRQR holding steady in market colapse odds are for up in 3 days.

PRQR 1.38 start.

ProQR Therapeutics SCHEDULE 13G 02/04/2022
Amended: It`s a boy!!!!!!!!! Really they only missed a 100,000 shares bought by Wellington Management Group LLP that is runs a lot of Vanguard and ETF funds.....
https://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++ProQR+Therapeutics+N.V.++++++++++++++++Filed+by%3A+WELLINGTON+MANAGEMENT+GROUP+LLP/19559743.html

nm

Important area here for PRQR in the 8.40ish resistance. Hopefully we can get a volume surge.

Some Nov/Dec call options with $10 strike traded today.. time for the pps to get up there. Looking stable going into 2022. Q 1/2 will be big.

Im liking the setup. Come on PRQR, make the move. Bollinger says we’re close.

Lilly earnings tomorrow wonder if we get a mention

Investment Case On ProQR Therapeutics Gets More Enticing

Looks like the high 7’s are even better! Man somebody took the air out of this balloon today.

Murocman

Low $8’s is a great place to add, me thinks.

You to

Yep. Editas data validated PRQR. Continued new highs coming.

Good Luck!

News out , nice volume

Sweet

I see indications that PRQR is about to make a move up. We’ll see..

Mind if I ask what you saw ?

I think options activity is getting interesting.

What do you think of these guys ? Seems like $50 at some point ?

Oops. Sorry about that.

Oligonucleotides to treat eye disease

Is that for prqr ?

New Patent